NO933342L - Derivater av gp160 og vaksiner basert paa gp160 eller et derivat derav, inneholdende et adjuvans - Google Patents

Derivater av gp160 og vaksiner basert paa gp160 eller et derivat derav, inneholdende et adjuvans

Info

Publication number
NO933342L
NO933342L NO93933342A NO933342A NO933342L NO 933342 L NO933342 L NO 933342L NO 93933342 A NO93933342 A NO 93933342A NO 933342 A NO933342 A NO 933342A NO 933342 L NO933342 L NO 933342L
Authority
NO
Norway
Prior art keywords
derivative
adjuvance
derivatives
vaccines based
immunotherapeutic
Prior art date
Application number
NO93933342A
Other languages
English (en)
Other versions
NO933342D0 (no
Inventor
Frans Van Wijnendale
Moncef Slaoui
Claudine Bruck
Myriam Francotte
Suzy Kummert
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919106048A external-priority patent/GB9106048D0/en
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of NO933342L publication Critical patent/NO933342L/no
Publication of NO933342D0 publication Critical patent/NO933342D0/no

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)

Abstract

Denne oppfinnelse tilveiebringer nye, hovedsaklig ikke- spaltbare former av gp160, og vaksinepreparater inneholdende gpl60 eller et derivat derav, tilsatt hjelpestoffet 3-D-Mpl. Blandingene er egnet for immunterapeutisk og immunprofylaktisk behandling av HIV-infeksjoner.
NO933342A 1991-03-21 1993-09-20 Derivater av gp160 og vaksiner basert paa gp160 eller et derivat derav, inneholdende et adjuvans NO933342D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919106048A GB9106048D0 (en) 1991-03-21 1991-03-21 Vaccines
PCT/EP1991/002047 WO1992016556A1 (en) 1991-03-21 1991-10-25 Derivatives opf gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant

Publications (2)

Publication Number Publication Date
NO933342L true NO933342L (no) 1993-09-20
NO933342D0 NO933342D0 (no) 1993-09-20

Family

ID=26069888

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933342A NO933342D0 (no) 1991-03-21 1993-09-20 Derivater av gp160 og vaksiner basert paa gp160 eller et derivat derav, inneholdende et adjuvans

Country Status (1)

Country Link
NO (1) NO933342D0 (no)

Also Published As

Publication number Publication date
NO933342D0 (no) 1993-09-20

Similar Documents

Publication Publication Date Title
YU174491A (sh) Vakcine
SE7613851L (sv) Glukosaminderivat
UA40597C2 (uk) Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів
NO942771L (no) Oljebasert og vannbasert hjelpestoff-blanding
RU94042386A (ru) Вакцина против гепатита, содержащая 3-0-дезацилированный монофосфорил-липида, применение антигена гепатита для получения препарата для лечения гепатита, способ лечения гепатита
TW266228B (no)
AU553185B2 (en) Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them
PT1104306E (pt) Composicoes de cpg e adjuvantes de saponina e seus metodos
YU8192A (sh) Postupak za izradu pneumokoknog polisaharidnog imunogenog proteinskog konjugata
AU1955088A (en) Avirulent microbes, incapable of producing functional adenylate cyclase and cyclic AMP
HUP9801242A1 (hu) Hepatitis B vakcina
EP1170016A3 (en) Urease-based vaccine against helicobacter infection
MX9301706A (es) Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
CA2022420A1 (en) Escherichia coli vaccine
IL130075A0 (en) A vaccine for eliciting an immune response to an antigen in an animal
NO912825L (no) Fremgangsmaate for fremstilling av kokonjugatvaksiner omfattende im munogent protein, hiv-beslektede peptider og anioniske grupper.
CA2190344A1 (en) Quillaja saponin adjuvant and vaccine formulation containing same
PT789590E (pt) Imunopotenciacao induzida por quitosano
WO1992006113A3 (en) Derivatives of gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant
CA2095534A1 (en) Avirulent microbes and uses therefor
NO933342L (no) Derivater av gp160 og vaksiner basert paa gp160 eller et derivat derav, inneholdende et adjuvans
IL86675A (en) Immunogen containing non- infectious hiv particles and pharmaceutical compositions containing the same
FI971402A0 (fi) Menetelmä voimistettujen antigeenisten Helico-bacter-lajien ja niitä sisältävien rokotteiden valmistamiseksi
NO913131L (no) Immunogene konjugater av ikke-toksisk oligosakkarid fra bordetella pertussis lipoolysakkarid.
AU5061090A (en) Aids therapy